3,3,4,4-TETRADEUTERIOMIANSERIN
Compound with spectra: 1 NMR
| SpectraBase Compound ID | Gr6wMp6U3pz |
|---|---|
| InChI | InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3/i10D2,11D2 |
| InChIKey | UEQUQVLFIPOEMF-MKQHWYKPSA-N |
| Mol Weight | 268.4 g/mol |
| Molecular Formula | C18H162H4N2 |
| Exact Mass | 268.187756 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(3aR,6aR)-2-(2-Bromo-allyl)-5-methyl-4,6-dioxo-3-(R)-phenyl-hexahydro-pyrrolo[3,4-c]pyrazole-1-carboxylic acid methyl ester
(3aS,6aS)-2-(2-Bromo-allyl)-5-methyl-4,6-dioxo-3-(R)-phenyl-hexahydro-pyrrolo[3,4-c]pyrazole-1-carboxylic acid methyl ester
cis-1-Phenyl-3a,4,5,11b-tetrahydrodipyrrolo[1,2-a:3',2'-c]quinoline-2,6-dione
4a,7-dihydro-4a,6,8-trimethyl-7-oxo-2-phenyl-4H-cyclopenta[b]thieno[2,3-e]pyridine-3-carbonitrile
3',4'-dihydro-6',7'-dimethoxyspiro[3H-indole-3,1'(2'H)-isoquinolin]-2(1H)-one
pyrido[2,3-d]pyrimidine-5-carboxylic acid, 1,4-dihydro-2-mercapto-1-(3-methylphenyl)-7-(3-nitrophenyl)-4-oxo-
#22;(R,R,R)-2-[3-(3-[N-[2-(3,5-DICHLORO-4-METHOXYPHENYL)-ACETYLCARBOXYL]-2-CARBOBENZYLOXYAMINOPROPIONYLAMINO]-INDOL-7-YL)-5-IODO-4-METHOXYPHENYL]-2-METHOXYCARB
3'-(3",4"-Dimethylphenyl)-spiro[indoline[3,2']-thiazolidine]-2,4'-(1H)-dione
diethyl 5-({[3-bromo-5-(4-bromophenyl)-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-2-yl]carbonyl}amino)-3-methyl-2,4-thiophenedicarboxylate
(+-)-cis-3-Methoxy-2,4-diphenyl-2-cyclopenten-1-one-4-ol (S)-MTPA ester
| Title | Journal or Book | Year |
|---|---|---|
| Syntheses and NMR analyses of deuterated mianserins | Recueil des Travaux Chimiques des Pays-Bas | 1983 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.